12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. Celularity (CELU) saw a 44.7% increase, while NovoCure (NVCR) rose by 24.15%. Jasper Therapeutics (JSPR) and Nuvectis Pharma (NVCT) also saw upward movements of 22.18% and 14.85%, respectively. Bullfrog AI Hldgs (BFRG) and Venus Concept (VERO) stocks rose by 14.74% and 14.28%. On the downside, Aravive (ARAV) dropped by 43.2%, Processa Pharma (PCSA) by 26.35%, and ZyVersa Therapeutics (ZVSA), 60 Degrees (SXTP), Cano Health (CANO), and MAIA Biotechnology (MAIA) also experienced declines.
January 18, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aravive's shares decreased by 43.2%, with a market cap of $4.6 million.
A sharp decline in stock price could lead to negative sentiment and further short-term selling pressure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Celularity's stock surged by 44.7%, with a market cap of $52.8 million.
The significant surge in stock price indicates strong investor interest, which could lead to continued short-term momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
NovoCure's shares increased by 24.15%, with a market value of $1.6 billion.
A substantial increase in share price often leads to further investor interest, potentially driving the price up in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100